Achieve Life Sciences (ACHV) Return on Capital Employed (2011 - 2018)
Achieve Life Sciences (ACHV) posted Return on Capital Employed of 260.67% for Q4 2018, up 578.53% on a QoQ basis from 54.47% in Q3 2018, and down 10187.0% year-over-year from N/an in Q4 2017.
Achieve Life Sciences (ACHV) Return on Capital Employed (2011 - 2018) Analysis & Trends
Achieve Life Sciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 260.67% for Q4 2018.
- Quarterly Return on Capital Employed fell 10187.0% year-over-year to 260.67% in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 260.67% (down 10187.0% YoY) and the FY2019 annual result came in at 94.23%, down 40120.0% from the prior year.
- Return on Capital Employed was 260.67% for Q4 2018 at Achieve Life Sciences, up from 54.47% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 509.19% in Q1 2017 and bottomed at 189.91% in Q1 2018.
- A 4-year average of 170.25% and a median of 214.06% in 2016 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2017 — Return on Capital Employed jumped 16339 bps — and 2018, when it tumbled 69910 bps.
- Achieve Life Sciences' Return on Capital Employed stood at 117.82% in 2015, then soared by 82 bps to 214.06% in 2016, then surged by 69 bps to 362.54% in 2017, then slipped by 28 bps to 260.67% in 2018.
- Business Quant data shows ACHV's Return on Capital Employed at 260.67% in Q4 2018, 54.47% in Q3 2018, and 128.41% in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 260.67% |
| Sep 30, 2018 | -54.47% |
| Jun 30, 2018 | -128.41% |
| Mar 31, 2018 | -189.91% |
| Dec 31, 2017 | 362.54% |
| Sep 30, 2017 | 319.88% |
| Jun 30, 2017 | 304.92% |
| Mar 31, 2017 | 509.19% |
| Dec 31, 2016 | 214.06% |
| Sep 30, 2016 | 156.49% |
| Dec 31, 2015 | 117.82% |
| Dec 31, 2012 | 56.70% |
| Sep 30, 2012 | -96.32% |
| Jun 30, 2012 | -97.49% |
| Mar 31, 2012 | -136.96% |
| Dec 31, 2011 | -204.16% |
| Sep 30, 2011 | 1.84% |